Skip to Main Content

Iman Osman, MD

Professor, Ronald O. Perelman Department of Dermatology

Professor, Department of Medicine

Professor, Department of Urology

Iman Osman

Keywords
melanoma

Phone

212-263-9076

Fax

212-263-5819

Academic office

522 First Avenue

Smilow, 4th Floor, Suite 405

New York, NY 10016

Lab Website
Osman Lab
Is this your profile?
Edit profile

These focus areas and their associated publications are derived from medical subject headings from PubMed.
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

Positions

Professor, Ronald O. Perelman Department of Dermatology

Professor, Department of Medicine

Professor, Department of Urology

Associate Dean for Translational Research Support

Director, Interdisciplinary Melanoma Cooperative Group

Graduate Education

MD from National Cancer Institute

MD from Cairo University

Residency And Fellowship Training

Fellowship, Memorial Sloan-Kettering Cancer Center

The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients

Donnelly, Douglas; Bajaj, Shirin; Yu, Jaehong; Hsu, Miles; Balar, Arjun; Pavlick, Anna; Weber, Jeffrey; Osman, Iman; Zhong, Judy

Journal for immunotherapy of cancer. 2019 Aug 19; 7(1):222

Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM)

Ferguson, Robert; Archambault, Alexi; Simpson, Danny; Morales, Leah; Chat, Vylyny; Kazlow, Esther; Lax, Rebecca; Yoon, Garrett; Moran, Una; Shapiro, Richard; Pavlick, Anna; Polsky, David; Osman, Iman; Kirchhoff, Tomas

Scientific reports. 2019 Jul 15; 9(1):10173

Autoimmune genetic risk variants as germline biomarkers of response to melanoma immune-checkpoint inhibition

Chat, Vylyny; Ferguson, Robert; Simpson, Danny; Kazlow, Esther; Lax, Rebecca; Moran, Una; Pavlick, Anna; Frederick, Dennie; Boland, Genevieve; Sullivan, Ryan; Ribas, Antoni; Flaherty, Keith; Osman, Iman; Weber, Jeffrey; Kirchhoff, Tomas

Cancer immunology immunotherapy. 2019 Jun; 68(6):897-905

Impact of initial stage on metastatic melanoma survival

Wilson, Melissa A; Zhong, Judy; Rosenbaum, Brooke E; Utter, Kierstin; Moran, Una; Darvishian, Farbod; Polsky, David; Berman, Russell S; Shapiro, Richard L; Pavlick, Anna C; Osman, Iman

Melanoma research. 2019 Jun; 29(3):281-288

Microglandular Adenosis is an advanced precursor breast lesion with evidence of molecular progression to matrix-producing metaplastic carcinoma

Schwartz, Christopher J; Dolgalev, Igor; Yoon, Esther; Osman, Iman; Heguy, Adriana; de Miera, Eleazar Vega-Saenz; Nimeh, Diana; Jour, George; Darvishian, Farbod

Human pathology. 2019 Mar; 85:65-71

Development of Novel Mutation-Specific Droplet Digital PCR Assays Detecting TERT Promoter Mutations in Tumor and Plasma Samples

Corless, Broderick C; Chang, Gregory A; Cooper, Samantha; Syeda, Mahrukh M; Shao, Yongzhao; Osman, Iman; Karlin-Neumann, George; Polsky, David

Journal of molecular diagnostics. 2019 Mar; 21(2):274-285

Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy

Lattanzi, Michael; Lee, Yesung; Simpson, Danny; Moran, Una; Darvishian, Farbod; Kim, Randie H; Hernando, Eva; Polsky, David; Hanniford, Doug; Shapiro, Richard; Berman, Russell; Pavlick, Anna C; Wilson, Melissa A; Kirchhoff, Tomas; Weber, Jeffrey S; Zhong, Judy; Osman, Iman

Journal of the National Cancer Institute. 2019 Feb 01; 111(2):180-188

Revisiting the clinical and biologic relevance of partial PTEN loss in melanoma

Giles, Keith M; Rosenbaum, Brooke E; Berger, Marlies; Izsak, Allison; Li, Yang; Illa Bochaca, Irineu; Vega-Saenz de Miera, Eleazar; Wang, Jinhua; Darvishian, Farbod; Zhong, Hua; Osman, Iman

Journal of investigative dermatology. 2019 Feb; 139(2):430-438

See All Publications (158)

Read Story
Read Story
Read Story